| CTRI Number |
CTRI/2025/07/090222 [Registered on: 04/07/2025] Trial Registered Prospectively |
| Last Modified On: |
26/06/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Clinical correlations of kidney biopsies among patients with unexplained chronic kidney disease to aid better understanding of unexplained chronic kidney disease in the region |
|
Scientific Title of Study
|
Clinicopathologic correlation of kidney biopsies done in patients with unexplained chronic kidney disease – a prospective observational study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Namrata Rao S |
| Designation |
Additional Professor, Department of Nephrology |
| Affiliation |
Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
| Address |
Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow
Lucknow UTTAR PRADESH 226010 India |
| Phone |
09454360872 |
| Fax |
|
| Email |
snamratarao@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Vinay Pratap Singh |
| Designation |
Senior Resident, Department of Nephrology |
| Affiliation |
Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
| Address |
Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow
Lucknow UTTAR PRADESH 226010 India |
| Phone |
9140070226 |
| Fax |
|
| Email |
vinayps589@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Namrata Rao S |
| Designation |
Additional Professor, Department of Nephrology |
| Affiliation |
Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
| Address |
Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow
Lucknow UTTAR PRADESH 226010 India |
| Phone |
09454360872 |
| Fax |
|
| Email |
snamratarao@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| Dr Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow, India, PIN - 226010 |
|
|
Primary Sponsor
|
| Name |
Dr Namrata Rao S |
| Address |
Department of Nephrology, Dr Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Lucknow - 226010 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Namrata Rao S |
Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
OPD No. 39, Ground Floor, OPD Block, Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow Lucknow UTTAR PRADESH |
09454360872
snamratarao@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N189||Chronic kidney disease, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
The diagnosis of unexplained chronic kidney disease will be made using:
1. Those with short duration of renal-specific symptoms and no baseline renal function tests available
2. Those with short duration of hypertension and no ophthalmoscopic findings of hypertensive retinopathy
3. Those with normal sized kidneys with/ without alterations of corticomedullary echotexture on ultrasound examination, but no urinary tract obstruction, stones, multiple cysts (defined as the presence of three or more (unilateral or bilateral) renal cysts in individuals aged 15 to 39 years, two or more cysts in each kidney is sufficient for individuals aged 40 to 59 years, and four or more cysts in each kidney is required for individuals more than 60 yr.)or single kidney
4. Those with non-nephrotic proteinuria with/without urinary sediment changes
5. Non-diabetic/ Diabetic without diabetic retinopathy
6. No previous kidney biopsy suggestive of another basic kidney disease
Screening inclusion criteria :Patients Decisioned for kidney biopsy for “unexplained renal failure”, per institutional protocol, by treating nephrologist (eGFR less than 60 ml/min/1.73m2) with/without urinary sediment abnormalities, who
1. are adults more than 18 years of age
2. giving informed consent for participation in study
Final inclusion criteria:
1. Availability of baseline eGFR 3 months or earlier less than 60 ml/min/1.73 m2 or
2. For study participants without baseline eGFR, follow-up for next 3 months with follow-up eGFR less than 60 ml/min/1.73 m2
|
|
| ExclusionCriteria |
| Details |
Patients not fulfilling institutional criteria for “unexplained renal failure” (positive serologies, underlying diabetes mellitus with diabetic retinopathy, longstanding hypertension with more than two anti-hypertensive drug use and presence of hypertensive retinopathy, long-term use of NSAIDs, among others)
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To estimate the prevalence of chronic tubulointerstitial inflammation and/or fibrosis (CTIN) among renal biopsies performed in patients for unexplained renal failure having chronic kidney disease |
To estimate the prevalence of chronic tubulointerstitial inflammation and/or fibrosis (CTIN) among renal biopsies performed in patients for unexplained renal failure having chronic kidney disease - of successive patients for study duration of 2 years |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To examine clinical characteristics that can predict chronic tubulointerstitial nephritis on renal biopsy |
To examine clinical characteristics that can predict chronic tubulointerstitial nephritis on renal biopsy - of successive patients for study duration of 2 years |
| To compare the serum levels of heavy metals between groups of patients with chronic kidney disease designated as chronic tubulointerstitial nephritis, chronic glomerulonephritis and combined findings (chronic tubulointerstitial nephritis and glomerulosclerosis) |
To compare the serum levels of heavy metals between groups of patients with chronic kidney disease designated as chronic tubulointerstitial nephritis, chronic glomerulonephritis and combined findings (chronic tubulointerstitial nephritis and glomerulosclerosis) - of successive patients for study duration of 2 years |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
15/07/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - None of the above
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [snamratarao@yahoo.co.in].
- For how long will this data be available start date provided 02-11-2027 and end date provided 02-11-2032?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
CKDu
has been described in endemic hotspots globally for the last few decades,
appearing as chronic interstitial nephritis in predominantly agricultural
communities in tropical climates such as India, Sri Lanka, and many South and
Central American countries.The majority of reports of CKDu in India come
from southern India, where the climate remains hot and humid through the year;
however, CKDu hotspots have been described in Kanpur from Uttar Pradesh, and in
Chattisgarh and Punjab too, where temperature and relative humidity dip
significantly in the winter months. Whether these northern Indian hotspots
correspond to CKDu or not, is presently unclear.
The
histopathologic characteristics in CKDu are predominantly those of chronic
tubulointerstitial nephritis, albeit with a host of other biopsy findings
(glomerulosclerosis, interstitial fibrosis, microvascular changes) described in
biopsies done from identified hotspots of CKDu. These histologic features may
vary between various agricultural communities from different parts of the
world. Characterizing these histopathologic features, correlating the same with
the history of exposure to agrochemicals, heat stress and other putative CKDu
causative factors, and also measuring blood and urine levels of these heavy
metals and agrochemicals, will prove to be an essential step in further
research work into CKDu in this region. In the last two decades, various
epidemiologic and environmental studies have elucidated on the role of exposure
to pesticides in the development of CKD. These studies have been performed,
both in patients affected by CKD as well as in population-based studies in
farming communities. Pesticides such as organophosphate and glyphosate have
been linked to the development of CKDu in Sri Lanka, to a certain extent.
However, the lack of uniformity of findings across studies in the MesoAmerican
region, and the lack of similar studies in India, make it difficult to
attribute the disease to these causes alone. Assessment
On the day of
the biopsy, 5 ml of blood and be drawn from patients of “unexplained renal
failure” undergoing biopsy with informed consent.
Pathological
Assessments:
Renal biopsy sample would be analysed under
light microscopy and Immunofluoroscence (IF) study and reported by
Nephropathologist at Dr. RMLIMS, Lucknow
Findings on the
biopsy are noted – including percentage of sclerosed glomeruli, percentage of
tubular atrophy, percentage of interstitial fibrosis, percentage of TI
inflammation, whether glomerular immune deposits are seen or not on IF (+/-
endocapillary/mesangial hypercellularity). They will be divided into following
groups
1.CTIN- Purely
chronic tubulointerstitial inflammation/ fibrosis OR Chronic tubulointerstitial
inflammation more intense than glomerulosclerosis (viable glomeruli
unremarkable) and negative IF
2. DGGS + CTIN
(negative IF)- Equal intensity of chronic tubulointerstitial inflammation/
fibrosis and glomeruloslerosis (viable glomeruli unremarkable) and negative IF
3. CGN: More
intense glomerulosclerosis (viable glomeruli showing abnormalities other than
periglomerular fibrosis) than chronic tubulointerstitial inflammation/
fibrosis. Negative/ positive IF
Biochemical
Assessments:
Estimation of heavy metals in serum (Cadmium, Lead, Aluminum, Copper, Mercury,
Calcium, Iron, Sodium, and Zinc)
The clinical and
biochemical details will be noted from the file and hospital information
system, after taking informed consent from the patients
Statistical analysis (relevant to thesis)
Data analysis will be done by using SPSS version 16 (IBM Inc., WA, USA). A
p-value of < 0.05 will be considered statistically significant
Comparisons between CTIN, DGGS + CTIN (Negative IF) and CGN groups in terms
of clinical, biochemical characteristics and parameters as per
questionnaire would be done.
Continuous variables would be assessed using unpaired t-test, while
categorical variables would be assessed using Pearson chi-square test.
Logistic regression will be performed to look for risk factors for CTIN on
renal biopsies. |